合成和药理学表征诺西丁/孤儿素FQ二度性联体
Valentina Albanese1, Pietro Pola2, Michela Argentieri2
1Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy.
Journal of medicinal chemistry
|November 4, 2025
概括
研究人员开发了一种新型的同位素诺西塞/孤儿素FQ (N/OFQ) 衍生物. 这些化合物在NOP受体上显示出增强的效能和作用时间,这表明长效疗法的有希望的策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
- 神经科学是一个神经科学.
背景情况:
- 神经白蛋白nociceptin/orphanin FQ (N/OFQ) 对生理调节至关重要.
- 它的受体NOP对各种疾病具有治疗点.
研究的目的:
- 为了合成和评估同位基N/OFQ-NH2衍生物.
- 探索多元化作为开发长效NOP受体配体的战略.
主要方法:
- 通过二硫化物键合成同质基N/OFQ-NH2衍生物.
- 使用NOP-G蛋白相互作用BRET和调动试验进行体外评估.
- 在小鼠体内评估N/OFQ-NH2衍生物1h.
主要成果:
- 化合物1h是一种由Leu14-to-Cys替代形成的二元体,表现出高强度 (pEC50 > 9).
- 1h在体内表现出比N/OFQ大3倍的功效.
- 长时间的效果1小时被观察到长达7小时.
结论:
- 对N/OFQ-NH2衍生物的多重化是一种可行的策略.
- 开发的化合物代表了有前途的长效基NOP受体连接体,用于治疗开发.
相关概念视频
Opioid Receptors: Overview
4.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.0K
Drug-Receptor Interaction: Agonist
3.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.8K
Nociception
33.0K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
33.0K
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
906
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
906
The Two-State Receptor Model
3.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.0K


